In addition, it was reported that the oral or intravenous administration of lactoferrin exhibited potent hepatoprotection against obstructive jaundiced rats [67], hepatic amoebiasis model hamster [68], d-GalN/LPS-induced hepatitis model mice [69], carbon tetrachloride-induced hepatitis model mice [69], and chemical-induce rat liver fibrosis [70]. Here, LTF is linked to hepatitis A virus infection.